Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice
pubmed: wnt1 2024-05-20
Summary:
CONCLUSION: PFD inhibited mammary tumor growth and alcohol-promoted metastasis. Since PFD is an FDA-approved drug, the current findings may be helpful to re-purpose its application in treating aggressive breast cancer and alcohol-promoted mammary tumor progression.